NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
school
University Rankings
subject
University Subject Rankings
place
Country Rankings
insights
i10 Productivity Rankings
insights
Subject Rankings
format_list_numbered
Top 100 Scientists
format_list_numbered
Citation Rankings
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Branka Powter
AD Scientific Index 2024
Others
University of New South Wales - Sydney / Australia
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Branka Powter's MOST POPULAR ARTICLES
1-)
BRAF inhibitor resistance mechanisms in metastatic melanoma: spectrum and clinical impactH Rizos, AM Menzies, GM Pupo, MS Carlino, C Fung, J Hyman, LE Haydu, ...Clinical cancer research 20 (7), 1965-1977, 20145212014
2-)
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanomaMS Carlino, JR Todd, K Gowrishankar, B Mijatov, GM Pupo, C Fung, ...Molecular oncology 8 (3), 544-554, 20141272014
3-)
Control of NF‐kB activity in human melanoma by bromodomain and extra‐terminal protein inhibitor I‐BET 151SJ Gallagher, B Mijatov, D Gunatilake, K Gowrishankar, J Tiffen, W James, ...Pigment cell & melanoma research 27 (6), 1126-1137, 2014872014
4-)
Mutant B-RAF-Mcl-1 survival signaling depends on the STAT3 transcription factorTM Becker, SC Boyd, B Mijatov, K Gowrishankar, S Snoyman, GM Pupo, ...Oncogene 33 (9), 1158-1166, 2014762014
5-)
Histone deacetylases (HDACs) as mediators of resistance to apoptosis in melanoma and as targets for combination therapy with selective BRAF inhibitorsF Lai, L Jin, S Gallagher, B Mijatov, XD Zhang, P HerseyAdvances in pharmacology 65, 27-43, 2012712012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept